環球實業科技(01026.HK):環業及弘舜按比例對擎琿增資1億元
格隆匯 12 月 3日丨環球實業科技(01026.HK)宣佈,於2020年12月3日,擎琿(由集團持有其49%的附屬公司)與擎琿股東(環業及弘舜的統稱)訂立出資協議,據此,擎琿股東同意增加擎琿的實繳註冊資本,由環業及弘舜按彼等各自在擎琿的表決權比例49:51額外出資合共實繳註冊資本人民幣1億元。
緊接出資協議完成前及後,擎琿的實繳註冊資本(包括表決權、股息及盈餘資本權利)分別由環業及弘舜擁有49%及51%。
公告稱,出資協議旨在提供額外資金以壯大擎琿的資本規模,藉以支持其業務發展,融資選項及投資機會。由於出資乃按環業及弘舜各自於擎琿的表決權比例按比例進行,故董事認為出資的條款屬公平合理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.